Hippo DX Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 13

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $5.14M

  • Investors
  • 4

Hippo DX General Information

Description

Developer of a skin prick allergy testing system intended to offer accurate and consistent allergy testing and readout. The company's system uses robotics and artificial intelligence to streamline pricking, imaging, and automate measurements with readout features that measure and annotate wheal sizes based on the cut-off value, enabling physicians to detect allergic patients in a simplified way.

Contact Information

Formerly Known As
Hippocreates
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Kempische Steenweg 303
  • Bus 200
  • 3500 Hasselt
  • Belgium
+32 016
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Technology Systems
Corporate Office
  • Kempische Steenweg 303
  • Bus 200
  • 3500 Hasselt
  • Belgium
+32 016

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hippo DX Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 20-Sep-2023 $5.14M Completed Clinical Trials - General
3. Early Stage VC 07-Dec-2021 Completed Clinical Trials - General
2. Accelerator/Incubator 01-Jul-2020 $135K $135K Completed Startup
1. Accelerator/Incubator Completed Startup
To view Hippo DX’s complete valuation and funding history, request access »

Hippo DX Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B Shares
B Shares
Ordinary
Ordinary 93,800 $0.62 $0.62 1x $0.62 1.29%
Ordinary 218,800 $0.37 $0.37 1x $0.37 3%
To view Hippo DX’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Hippo DX Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a skin prick allergy testing system intended to offer accurate and consistent allergy testing and readout.
Diagnostic Equipment
Hasselt, Belgium
13 As of 2026

San Sebastian, Spain
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hippo DX Competitors (1)

One of Hippo DX’s competitors is Nexkin, a Venture Capital-Backed company based in San Sebastian, Spain.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Nexkin Venture Capital-Backed San Sebastian, Spain
You’re viewing 1 of 1 competitors. Get the full list »

Hippo DX Patents

Hippo DX Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022218319-A1 Detection and metrology of allergen skin reaction Inactive 02-Feb-2021
CA-3209612-A1 Detection and metrology of allergen skin reaction Pending 02-Feb-2021
EP-4035589-A1 Detection and metrology of allergen skin reaction Inactive 02-Feb-2021
EP-4287931-A1 Detection and metrology of allergen skin reaction Active 02-Feb-2021
EP-4287931-B1 Detection and metrology of allergen skin reaction Active 02-Feb-2021 A61B5/411
To view Hippo DX’s complete patent history, request access »

Hippo DX Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hippo DX Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
AllerFund Ventures Venture Capital Minority
LRM Venture Capital Minority
Imec.istart Accelerator/Incubator Minority
Corda Campus Accelerator/Incubator
To view Hippo DX’s complete investors history, request access »

Hippo DX FAQs

  • When was Hippo DX founded?

    Hippo DX was founded in 2020.

  • Where is Hippo DX headquartered?

    Hippo DX is headquartered in Hasselt, Belgium.

  • What is the size of Hippo DX?

    Hippo DX has 13 total employees.

  • What industry is Hippo DX in?

    Hippo DX’s primary industry is Diagnostic Equipment.

  • Is Hippo DX a private or public company?

    Hippo DX is a Private company.

  • What is the current valuation of Hippo DX?

    The current valuation of Hippo DX is .

  • What is Hippo DX’s current revenue?

    The current revenue for Hippo DX is .

  • How much funding has Hippo DX raised over time?

    Hippo DX has raised $6.98M.

  • Who are Hippo DX’s investors?

    AllerFund Ventures, LRM, Imec.istart, and Corda Campus have invested in Hippo DX.

  • Who are Hippo DX’s competitors?

    Nexkin is a competitor of Hippo DX.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process